Inception Return
(3/28/2008)
|
8.09 %
|
|
YTD Return
|
-5.83 %
|
|
NAVPS
(6/5/2020)
|
$22.90
|
|
Change
|
$0.18 / 0.80 %
|
|
|
Growth of $10,000
(As of April 30, 2020)
|
|
MER
|
2.51 %
|
|
Assets ($mil)
|
$834.37
|
|
Rank (1Yr)
|
240/1375
|
|
Std Dev (3Yr)
|
11.31 %
|
|
Volatility Ranking (3Yr)
|
5/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Choice of Front or Back
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
5.50 %
|
|
Sales Status
|
Open
|
|
|
Objective
The Fund seeks long-term capital growth and current income, by investing primarily in equity securities of companies anywhere in the world that pay, or may be expected to pay, dividends. The Fund may also invest in other types of securities that distribute, or may be expected to distribute, income.
|
Management Co.
Mackenzie Financial Corporation
Managers
Darren McKiernan, Eugene Profis, Ome Saidi
|
|
Asset Allocation
(As of February 29, 2020)
|
Sector Allocation
(As of February 29, 2020)
|
Geographic Allocation
(As of February 29, 2020)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Cash and Cash Equivalents | Cash and Equivalents | Cash and Cash Equivalent | Canada | 3.45% |
| Microsoft Corp | US Equity | Technology | United States | 2.95% |
| Nestle SA | International Equity | Consumer Goods | Other European | 2.64% |
| Deutsche Boerse AG | International Equity | Financial Services | European Union | 2.45% |
| JPMorgan Chase & Co | US Equity | Financial Services | United States | 2.40% |
| Becton Dickinson and Co | US Equity | Healthcare | United States | 2.35% |
| Roche Holding AG - Participation | International Equity | Healthcare | Other European | 2.13% |
| Philip Morris International Inc | US Equity | Consumer Goods | United States | 2.09% |
| Novo Nordisk A/S Cl B | International Equity | Healthcare | European Union | 1.90% |
| Sherwin-Williams Co | US Equity | Basic Materials | United States | 1.87% |
Performance Data
(As of April 30, 2020)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
7.59
|
-6.82
|
-2.14
|
-5.83
|
0.40
|
3.63
|
7.09
|
10.00
|
|
Benchmark
|
8.64
|
-7.97
|
-3.08
|
-8.10
|
-2.16
|
4.84
|
7.40
|
10.56
|
|
Quartile Ranking
|
3
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
|
Calendar Return (%)
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
2013
|
2012
|
2011
|
2010
|
|
Fund
|
23.27
|
-5.35
|
12.83
|
4.61
|
20.69
|
12.84
|
17.68
|
7.70
|
6.16
|
6.49
|
|
Benchmark
|
21.41
|
-1.79
|
16.29
|
5.18
|
16.88
|
13.97
|
32.40
|
13.73
|
-5.69
|
8.11
|
|
Quartile Ranking
|
1
|
2
|
2
|
2
|
1
|
1
|
4
|
4
|
1
|
2
|
MSCI ESG Fund Metrics (As of May 01, 2020)
|
The MSCI ESG Quality Score measures the ability of underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors.
|
|
The percentage of the portfolio's market value exposed to companies flagged for one or more standard SRI exclusion factors (alcohol, civilian firearms, gambling, weapons, cluster bombs, landmines, nuclear power, GMOs, and tobacco).
|
The portfolio weighted average of each company’s percent of revenue generated by Sustainable Impact Solutions (goods and services that address at least one of the world’s social and environmental challenges), as defined by the United Nations Sustainable Development Goals.
|
ESG data provided by MSCI
MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted to, nor received approval from, the US SEC or any other regulatory body. None of the Information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information.